Parallax Volatility Advisers’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-16,500
Closed -$1.2M 3279
2020
Q4
$1.2M Buy
+16,500
New +$956K ﹤0.01% 2106
2019
Q3
Sell
-9,000
Closed -$324K 2388
2019
Q2
$324K Sell
9,000
-9,000
-50% -$288K ﹤0.01% 1622
2019
Q1
$568K Buy
+18,000
New +$524K ﹤0.01% 1483

Other funds holding CDNA

Parallax Volatility Advisers's CDNA Position: Q1 2021 in Review

Parallax Volatility Advisers sold out of CareDx (CDNA) in Q1 2021, closing a stake of 741 shares — an estimated $54K sold.

Parallax Volatility Advisers first reported a position in CDNA in Q3 2018 and held it in 3 quarters. The position peaked at $138K in Q1 2019. 245 funds tracked by Wall St. Rank hold CDNA as of Q1 2021.

  • Parallax Volatility Advisers reported no remaining CareDx position as of Q1 2021 after selling out during the quarter.
  • Parallax Volatility Advisers sold 741 CareDx shares in Q1 2021, an estimated $54K.
  • Parallax Volatility Advisers first reported a position in CareDx in Q3 2018 and held it in 3 quarters.
  • Parallax Volatility Advisers's CareDx position peaked at $138K in Q1 2019.
  • 245 funds tracked by Wall St. Rank held CareDx as of Q1 2021.

Based on Parallax Volatility Advisers's 13F filing for Q1 2021, filed 14 May 2021.